Children who experience undernutrition may benefit from weight gain during their first decade of life, leading to taller adults without…
Browsing: Obesity
The obesity market is currently dominated by Novo Nordisk and Eli Lilly, the only companies with approved GLP-1s. However, with…
Credit: Unsplash/CC0 Public Domain As Australia faces a turning point in obesity management, researchers from Monash University have contributed new…
The Roche deal was a validation of Zealand’s approach to tackling obesity with novel peptide-based therapies. It showed that the…
Access to Weight Loss Drug Wegovy Still Limited Despite Medicaid Coverage in South Carolina CHARLESTON, S.C. — Page Campbell, a…
Novo Nordisk and Eli Lilly have established themselves as the market leaders in the obesity drug sector with their GLP-1…
Pfizer Halts Development of Obesity Pill Due to Liver Injury Concerns Pfizer has made the decision to discontinue the development…
Novo Nordisk Makes Bold Move in Obesity Market with New Triple Agonist Danish biopharma giant Novo Nordisk is making waves…
The FDA’s recent decisions regarding compound GLP-1s have had a significant impact on the obesity drug market, particularly for pharma…
Roche stood out because they had thought the most about how to lead in this space and we believed they…
